116 related articles for article (PubMed ID: 8700545)
41. Refined chromosomal localization of the human thrombopoietin gene to 3q27-q28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26.
Schnittger S; de Sauvage FJ; Le Paslier D; Fonatsch C
Leukemia; 1996 Dec; 10(12):1891-6. PubMed ID: 8946927
[TBL] [Abstract][Full Text] [Related]
42. Acute panmyelosis with myelofibrosis with EVI1 amplification.
Grygalewicz B; Woroniecka R; Pastwińska A; Rygier J; Krawczyk P; Borg K; Makuch-Łasica H; Patkowska E; Pieńkowska-Grela B
Cancer Genet; 2012 May; 205(5):255-60. PubMed ID: 22682625
[TBL] [Abstract][Full Text] [Related]
43. Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region.
Fichelson S; Dreyfus F; Berger R; Melle J; Bastard C; Miclea JM; Gisselbrecht S
Leukemia; 1992 Feb; 6(2):93-9. PubMed ID: 1552747
[TBL] [Abstract][Full Text] [Related]
44. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome.
Hamaguchi H; Suzukawa K; Nagata K; Yamamoto K; Yagasaki F; Morishita K
Br J Haematol; 1997 Aug; 98(2):399-407. PubMed ID: 9266939
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of Evi-1 and dysmegakaryopoiesis in human leukemias: reply to Carapeti, Goldman and Cross, Leukemia 1996; 10: 1561.
Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Hirai H
Leukemia; 1996 Nov; 10(11):1849. PubMed ID: 8892696
[No Abstract] [Full Text] [Related]
46. Identification of candidate target genes for EVI-1, a zinc finger oncoprotein, using a novel selection strategy.
Kim JH; Hui P; Yue D; Aycock J; Leclerc C; Bjoring AR; Perkins AS
Oncogene; 1998 Sep; 17(12):1527-38. PubMed ID: 9794230
[TBL] [Abstract][Full Text] [Related]
47. [Hematologic and clinical features of 3q21q26 syndrome: extremely poor prognosis and association with central diabetes insipidus].
Chung HJ; Seo EJ; Kim KH; Jang S; Park CJ; Chi HS; Lee JH; Lee JH; Lee KH
Korean J Lab Med; 2007 Apr; 27(2):133-8. PubMed ID: 18094565
[TBL] [Abstract][Full Text] [Related]
48. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
[TBL] [Abstract][Full Text] [Related]
49. Double Inv(3)(q21q26), a rare but recurrent chromosomal abnormality in myeloid hemopathies.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Ianotto JC; Berthou C; Gueganic N; Bovo C; Basinko A; Morel F; De Braekeleer M
Anticancer Res; 2013 Feb; 33(2):639-42. PubMed ID: 23393360
[TBL] [Abstract][Full Text] [Related]
50. Rearrangements of chromosome band 3q21 in myeloid leukemia.
Wieser R
Leuk Lymphoma; 2002 Jan; 43(1):59-65. PubMed ID: 11908737
[TBL] [Abstract][Full Text] [Related]
51. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.
Morishita K; Parganas E; William CL; Whittaker MH; Drabkin H; Oval J; Taetle R; Valentine MB; Ihle JN
Proc Natl Acad Sci U S A; 1992 May; 89(9):3937-41. PubMed ID: 1570317
[TBL] [Abstract][Full Text] [Related]
52. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes.
Morishita K; Parganas E; Parham DM; Matsugi T; Ihle JN
Oncogene; 1990 Sep; 5(9):1419-23. PubMed ID: 1699199
[TBL] [Abstract][Full Text] [Related]
53. [Characteristics of cases with chromosome 3q21q26 aberrations].
Zhang Y; He Q; Shi Y; Dang H; Qiu JY; Huang XJ; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):22-5. PubMed ID: 18315893
[TBL] [Abstract][Full Text] [Related]
54. A discriminating screening is necessary to ascertain EVI1 expression by RT-PCR in malignant cells from the myeloid lineage without 3q26 rearrangement.
Zoccola D; Legros L; Cassuto P; Fuzibet JG; Nucifora G; Raynaud SD
Leukemia; 2003 Mar; 17(3):643-5. PubMed ID: 12646959
[No Abstract] [Full Text] [Related]
55. Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia.
Pekarsky Y; Rynditch A; Wieser R; Fonatsch C; Gardiner K
Cancer Res; 1997 Sep; 57(18):3914-9. PubMed ID: 9307271
[TBL] [Abstract][Full Text] [Related]
56. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.
Bartholomew C; Ihle JN
Mol Cell Biol; 1991 Apr; 11(4):1820-8. PubMed ID: 1848663
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of EVI-1 in blast crisis of chronic myeloid leukemia.
Carapeti M; Goldman JM; Cross NC
Leukemia; 1996 Sep; 10(9):1561. PubMed ID: 8751483
[No Abstract] [Full Text] [Related]
58. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.
Shimabe M; Goyama S; Watanabe-Okochi N; Yoshimi A; Ichikawa M; Imai Y; Kurokawa M
Oncogene; 2009 Dec; 28(49):4364-74. PubMed ID: 19767769
[TBL] [Abstract][Full Text] [Related]
59. Acute myelogenous leukemia with monosomy 7, inv(3) (q21q26), involving activated EVI 1 gene occurring after a complete remission of lymphoblastic lymphoma: a case report.
Igarashi T; Shimizu S; Morishita K; Ohtsu T; Itoh K; Minami H; Fujii H; Sasaki Y; Mukai K
Jpn J Clin Oncol; 1998 Nov; 28(11):688-95. PubMed ID: 9861236
[TBL] [Abstract][Full Text] [Related]
60. Expression of the Evi-1 gene in myelodysplastic syndromes.
Dreyfus F; Bouscary D; Melle J; Ribrag V; Guesnu M; Varet B
Leukemia; 1995 Jan; 9(1):203-5. PubMed ID: 7845018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
